Portfolio company
VERO Biotech
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops tankless inhaled nitric oxide delivery systems for hospitals treating patients with pulmonary and cardiac conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Vaporox
This company develops medical devices for healing chronic wounds by delivering concentrated oxygen and water vapor to healthcare facilities and clinics.
Attgeno
This company develops nitric oxide-donating drugs to treat patients with acute pulmonary hypertension and other conditions requiring targeted organ delivery.
HBOX
This company develops respiratory support devices that use hyperbaric blood oxygenation to treat patients with acute lung failure.
Peroxitech Therapeutics
Peroxitech Therapeutics develops peptide-based treatments for acute lung injury and respiratory distress to serve patients with severe inflammatory conditions.
Kither Biotech
This company develops inhaled therapies for patients with respiratory diseases such as chronic obstructive pulmonary disease and cystic fibrosis.
Breath Therapeutics
This biopharmaceutical company develops inhaled drug-aerosol therapies for patients with bronchiolitis obliterans syndrome and other severe respiratory diseases.
Aria CV, Inc
This medical technology company develops an implantable balloon system to treat pulmonary arterial hypertension by restoring vessel compliance and reducing cardiac workload.
Volusense
The company develops non-invasive, mask-free respiratory monitoring systems used by neonatologists and paediatricians to evaluate lung function in preterm and term infants.
